Nuveen’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $661M | Sell |
|
|||||
|
2025
Q1 | $555M | Sell |
|
|||||
|
2024
Q4 | $633M | Buy |
|
|||||
|
2024
Q3 | $542M | Buy |
|
|||||
|
2024
Q2 | $730M | Sell |
|
|||||
|
2024
Q1 | $1.01B | Sell |
|
|||||
|
2023
Q4 | $931M | Sell |
|
|||||
|
2023
Q3 | $723M | Sell |
|
|||||
|
2023
Q2 | $1.02B | Buy |
|
|||||
|
2023
Q1 | $913M | Buy |
|
|||||
|
2022
Q4 | $874M | Sell |
|
|||||
|
2022
Q3 | $686M | Buy |
|
|||||
|
2022
Q2 | $618M | Sell |
|
|||||
|
2022
Q1 | $1.01B | Buy |
|
|||||
|
2021
Q4 | $1.1B | Sell |
|
|||||
|
2021
Q3 | $1.15B | Buy |
|
|||||
|
2021
Q2 | $782M | Buy |
|
|||||
|
2021
Q1 | $463M | Buy |
|
|||||
|
2020
Q4 | $403M | Buy |
|
|||||
|
2020
Q3 | $331M | Buy |
|
|||||
|
2020
Q2 | $299M | Sell |
|
|||||
|
2020
Q1 | $265M | Sell |
|
|||||
|
2019
Q4 | $217M | Sell |
|
|||||
|
2019
Q3 | $155M | Sell |
|
|||||
|
2019
Q2 | $166M | Buy |
|
|||||
|
2019
Q1 | $7.01M | Buy |
|
|||||
|
2018
Q4 | $4.89M | Sell |
|
|||||
|
2018
Q3 | $6.75M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $6.13M | Sell |
|
|||||
|
2017
Q2 | $9.57M | Sell |
|
|||||
|
2017
Q1 | $12.9M | Buy |
|
|||||
|
2016
Q4 | $4.38M | Sell |
|
|||||
|
2016
Q3 | $12.5M | Sell |
|
|||||
|
2016
Q2 | $14.4M | Buy |
|
|||||
|
2016
Q1 | $1.36K | Sell |
|
|||||
|
2015
Q4 | $16.8K | Sell |
|
|||||
|
2015
Q3 | $19.1K | Buy |
|
|||||
|
2015
Q2 | $16.3K | Sell |
|
|||||
|
2015
Q1 | $16.5M | Buy |
|
|||||
|
2014
Q4 | $320K | Sell |
|
|||||
|
2014
Q3 | $241K | Buy |
|
|||||
|
2014
Q2 | $234K | Hold |
|
|||||
|
2014
Q1 | $244K | Hold |
|
|||||
|
2013
Q4 | $209K | Buy |
|